ARTICLE | Company News
Aurum Biosciences, Oxygen Biotherapeutics deal
February 6, 2012 8:00 AM UTC
The companies partnered to develop a diagnostic and therapeutic to treat acute ischemic stroke using Oxygen's Oxycyte perfluorocarbon (PFC)-based therapeutic oxygen carrier in combination with Aurum's Glasgow Oxygen Level Dependent (GOLD) MRI techniques. The partners signed a letter of intent last July to evaluate the combination (see BioCentury, Sept. 26, 2011). ...